logo
15:42 Jun 24

Vivimed Labs Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
5.76
-0.15 (-2.54%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Vivimed Labs Ltd. Financials

Vivimed Labs Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
5.76
-0.15 (-2.54%)
15:42 Jun 24
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

14/100
Expensive Valuation

Technical

23/100
Technically Bearish

Strength

5

Weakness

13

Opportunity

0

Threats

0

-23,087.35 %

ROE %

-3.47 %

ROA %

-4.21

EPS

-4.24

BVPS

-27.48 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
237.29 187.1 149.07 116.27 83.6
Operating Expenses +
245.35 374.41 176.67 129.32 98.24
Raw Material
153 187.09 89.54 57.76 32.76
Increase Decrease in Cost
0.48 84.42 -18.07 2.09 5.5
Other Manufacturing Expense
28.06 17.55 16.47 0 0
Employee Cost
36.22 32.67 34.16 28.39 23.79
Miscellaneous Expenses
27.59 52.68 54.57 41.08 36.19
Operating Profit
-8.06 -187.31 -27.6 -13.05 -14.64
Other Income
1.27 0.97 9.98 4.37 4.81
Depreciation
18.28 108.41 19.94 20.22 20.04
Interest
39.76 35.9 2.43 2.95 4.98
Profit before tax and exceptio..
-64.83 -330.65 -39.99 -31.85 -34.85
Exceptional Items
0 0 0 0 0
PBT
-64.83 -330.65 -39.99 -31.85 -34.85
Provision for Taxation
2.82 -2.12 -0.38 0.11 0.11
Net Profit
-67.65 -328.53 -45.45 -31.96 -34.94
NET Profit after MI
-67.65 -328.53 -45.45 -31.96 -34.94
EPS
-7.92 -39.62 -5.48 -3.74 -4.22
Operating Profit Margin (%)
-3.4 -100.11 -18.51 -11.22 -17.51
Net Profit Margin (%)
-28.51 -175.59 -30.49 -27.49 -41.79

Vivimed Labs Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 7.60 7.80 7.80 7.80 20.90 20.90
FII 1.60 1.60 1.60 1.60 1.60 1.60
Public 0.20 0.20 0.20 0.20 0.20 0.20
Others 90.60 90.40 90.40 90.40 77.30 77.30
Shareholder Shares Holding %
Research 360 logo
Download Our App On: